source
- Health systems grapple with AI chatbot use, some block tools while others consider in-house solutionsFree AI chatbots designed for clinicians, such as OpenEvidence, Doximity Ask and ChatGPT for Clinicians, have become popular, with hundreds of thousands of doctors turning to them for clinical guid…
- Agios to cut over 202 R&D positions as it awaits FDA decision on sickle cell drugAgios Pharmaceuticals said it will eliminate more than 100 research and development positions by the end of 2026, cutting its R&D workforce by roughly 35% from 2025 levels. The company entered the…